- Tocilizumab, sold as RoActemra or Actemra, added to the UK's Recovery trial
- It's hoped the drug can help calm deadly immune reaction which inflames lungs
- Trial has already recruited about 6,000 NHS patients from 160 trusts in a month
Tuesday, 5 May 2020
critically-ill coronavirus patients will be given an arthritis drug in world's largest trial of promising therapies in NHS hospitals
Daily Mail
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment